[18F]flortaucipir PET
10 papers2 findings
- Humans10
Associations
2Cortical gray matter volume
downin humans1
1 study
Cortical gray matter volume
downin humans1
[18F]flortaucipir PET predicts cortical gray matter volume in humans.
“Severe longitudinal GM loss in fronto‐temporo‐parietal regions of the AD‐typical pattern was observed in the A+vT+ group”
Humanspreclinical Alzheimer's disease (A+)brain7.4 years57% femalesn = 334
Utility of tau biomarkers for detecting clinical outcomes in preclinical Alzheimer's disease
AAIC 2025 abstract25 Dec 2025
Cognitive function
downin humans1
1 study
Cognitive function
downin humans1
[18F]flortaucipir PET predicts cognitive function in humans (t=-10.3, p <0.001).
“Compared to the A+pTau‐vT‐ group, significant longitudinal declines in PACC scores were observed in the A+pTau+vT‐ (t=‐2.35, p = 0.02) and A+vT+ groups (t=‐10.3, p <0.001)”
Humanspreclinical Alzheimer's disease (A+)7.4 years57% femalesn = 334
Utility of tau biomarkers for detecting clinical outcomes in preclinical Alzheimer's disease
AAIC 2025 abstract25 Dec 2025
Latest
13 in 12 monthsAAIC 2025 Abstract
Prognostic utility of p ‐tau217 and tau PET in Alzheimer's disease
Cohort study of 156 peopleTau PET
AAIC 2025 Abstract
Evaluating Plasma Ptau‐217 Sensitivity in Detecting Individual Differences in Early‐stage Tau Aggregation in Cognitively Unimpaired Older Adults
Cohort study of 142 peopleBiomarkers
AAIC 2025 Abstract
Differential Performance of p ‐tau217 in Reflecting Amyloid and Tau Stages in Cognitively Unimpaired and Impaired Individuals
Cohort study of 237 peoplep-Tau217
AAIC 2025 Abstract
Implementation of NIA‐AA Multilevel Tau Staging for Predicting Tau Accumulation and Cognitive Decline in Non‐Demented Individuals
Cohort study of 213 peopleCognitive decline
AAIC 2025 Abstract
Lower Antemortem [ ¹⁸ F]flortaucipir PET retention in Males and Older Individuals is Explained by Lower Postmortem Tau Tangle Density
Cohort study of 947 peopleMechanisms
AAIC 2025 Abstract
Effects of AD modifiable risk factors to tau‐PET tracer uptake and its association with cognitiion in early Braak stages
Cohort study of 436 peoplePopulations
AAIC 2025 Abstract
Utility of tau biomarkers for detecting clinical outcomes in preclinical Alzheimer's disease
Cohort study of 334 peopleAlzheimer's disease
AAIC 2025 Abstract
Whole‐brain functional connectivity predicts regional tau PET and future cognitive decline in preclinical Alzheimer's disease
Cohort study of 469 peopleTau PET
AAIC 2025 Abstract
Specific centiloid thresholds to describe the continuum of amyloid and tau deposition
Cohort study of 580 peopleBiomarkers
AAIC 2025 Abstract
Evaluating Plasma Ptau‐217 Sensitivity in Detecting Individual Differences in Early‐stage Tau Aggregation in Cognitively Unimpaired Older Adults
Cohort study of 142 peopleBiomarkers